Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,513 | -6,132 | -1,788 | -8,811 | -5,862 |
| Depreciation Amortization | 486 | 320 | 157 | 478 | 312 |
| Accounts receivable | 11 | 36 | 13 | -42 | -93 |
| Accounts payable and accrued liabilities | -117 | -56 | 90 | -287 | 112 |
| Other Working Capital | -945 | -215 | 48 | -3,294 | -3,268 |
| Other Operating Activity | 2,503 | 1,894 | -371 | 1,156 | 504 |
| Operating Cash Flow | $-6,575 | $-4,153 | $-1,851 | $-10,800 | $-8,295 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 5,081 | 3,081 |
| PPE Investments | -152 | -125 | -93 | -1,423 | -1,381 |
| Purchase Of Investment | N/A | N/A | N/A | -149 | -149 |
| Purchase Sale Intangibles | -37 | -15 | -2 | -122 | -92 |
| Other Investing Activity | -37 | -15 | -2 | -122 | -92 |
| Investing Cash Flow | $-189 | $-140 | $-95 | $3,387 | $1,459 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 530 | N/A |
| Debt Repayment | -2 | -1 | N/A | N/A | 530 |
| Common Stock Issued | 4,145 | 4,145 | 726 | 14,158 | N/A |
| Financing Cash Flow | $4,143 | $4,144 | $726 | $14,688 | $530 |
| Exchange Rate Effect | 14 | 0 | -9 | 15 | 16 |
| Beginning Cash Position | 14,548 | 14,548 | 14,548 | 7,258 | 7,258 |
| End Cash Position | 11,941 | 14,399 | 13,319 | 14,548 | 968 |
| Net Cash Flow | $-2,607 | $-149 | $-1,229 | $7,290 | $-6,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,575 | -4,153 | -1,851 | -10,800 | -8,295 |
| Capital Expenditure | N/A | -125 | -93 | -1,470 | -1,381 |
| Free Cash Flow | -6,575 | -4,278 | -1,944 | -12,270 | -9,676 |